ArticleCureus2025
Predictors of 30-Day Readmission in Patients With Heart Failure: A Retrospective Cohort Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Heart failure (HF) is a leading cause of hospitalizations and early readmissions, contributing significantly to morbidity, mortality, and healthcare costs. Identifying factors that predict 30-day readmission can help design targeted interventions to improve patient outcomes. Therefore, this study aimed to identify these predictors.. Methods A retrospective cohort study involving 300 patients with HF was conducted. Demographic, clinical, laboratory, comorbidity, and socioeconomic factors were analyzed. The primary objective was to identify clinical, laboratory, and comorbidity-related factors independently associated with 30-day hospital readmission in patients with HF. A secondary objective was to evaluate and interpret the performance of logistic regression and machine learning models (random forest and XGBoost) in predicting readmission risk. Results The cohort had a mean age of 68.4 ±10.2 years, with 186 (62%) males and 114 (38%) females. Readmission was observed in 93 (31%) patients. Readmitted patients more frequently had reduced left ventricular ejection fraction (LVEF <40%; 122, 41%), elevated B-type natriuretic peptide (BNP, 168; 56%), creatinine >1.5 mg/dL (87, 29%), and a Charlson Comorbidity Index (CCI) score ≥4 (196, 65.3%). Multivariate regression confirmed reduced LVEF (adjusted odds ratio (OR): 1.74, 95% confidence interval (CI): 1.09-2.96, p = 0.021), elevated creatinine (adjusted OR: 1.89, 95% CI: 1.11-3.11, p = 0.015), and higher CCI score (adjusted OR: 2.31, 95% CI: 1.41-3.77, p = 0.001) as independent predictors. Random forest achieved the best performance (accuracy 0.72, precision 0.61, recall 0.58, F1-score 0.59, area under the receiver operating characteristic (ROC-AUC) curve 0.44) but still showed poor discrimination (ROC-AUCs for logistic regression and XGBoost were 0.43 and 0.42, respectively). Conclusions Comorbidity burden, impaired renal function, and reduced cardiac function are key predictors of 30-day readmission in HF patients. Machine learning models provided useful interpretability but showed poor discrimination, highlighting their role as exploratory tools for hypothesis generation rather than significant improvements in predictive performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.